Randox QC Resource Hub

Home - QC

Randox QC Resource Hub

  • Brochures
  • Support Tools
  • Educational Items
  • Posters
  • Industry Articles
  • Webinars
  • Videos
  • Blog
  • Testimonials

Acusera Third Party Controls

Acusera 24•7

Infectious Disease Controls (Serology)

Importance of Third Party Controls

Acusera Point of Care Controls

Acusera Linearity Sets

IQC - Liquid 30 Day Controls

RIQAS External Quality Assessment

RIQAS Point of Care (RIQAS POC)

Qnostics - Molecular Infectious Disease Controls

QCMD - EQA for Molecular Infectious Disease Testing

International Brochures

Download our brochures in other languages

How to Establish QC Reference Ranges

The Cost of Poor Quality in the Clinical Laboratory

The Role of Six Sigma in a Modern QC Strategy

How Often Is Right For QC - Download

How Often Is Right For QC

How To Measure Uncertainty

ISO 15189:2012 Accreditation Guide

QC Multi-Rules

The Role of EQA in QC

Troubleshooting QC Errors

What Format Is Best For Your Laboratory - Download

What Format Is Best For Your Laboratory

Which QC is The Right QC - Downloads

Which QC is The Right QC

Basic QC Statistics

Commutability

Designing An Appropriate QC Design Procedure

ISO 15189 Requirements for Measurement Uncertainty

Quality Control for POCT - Download

Quality Control for POCT

Importance of Third Party Controls in Molecular Infectious Disease Testing

QC Statistics Infographic - Download

QC Statistics Infographic

The Difference Between IQC & EQA - Download

The Difference Between IQC & EQA

Linearity Verification Clinical Chemistry - Download

Linearity Verification Clinical Chemistry

Linearity Verification Cardiac - Download

Linearity Verification Cardiac

Using QC Multi-rules - Download

Using QC Multi-Rules

Preparing QC - Step-by-Step Guide - Download

Preparing QC - Step-by-Step Guide

Monitoring EQA Performance - Download

Monitoring EQA Performance

Guide to Running QC - Download

Guide to Running QC

RIQAS Frequency - Lipase

RIQAS Past Panels Flyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Using Sigma metrics and Measurement Uncertainty in QC – MLO

Using Sigma metrics and Measurement Uncertainty in QC – MLO

RIQAS Report Interpretation

Importance of Third Party Controls in Molecular Diagnostics

Fully syndromic approach to molecular testing

SARS-CoV-2 Proficiency Testing

RIQAS Reporting

The Role of EQA in QC Management

Importance of EQA

Utilisation of QC Software for Identification of Performance Issues

Why is the third party QC important for COVID-19 detection in Molecular testing

Importance of Third Party Controls in Molecular Diagnostics

Performance & Statistics - How EQA Can Help You Excel

Acusera 24•7 Webinar: Utilisation of QC software and metrics to help identify performance issues

The Need for Robust Molecular Quality Assurance in the Wake of the Pandemic

Acusera Third Party Controls

True Third Party Controls

Randox Acusera Quality Controls

Consolidation

RIQAS – External Quality Assessment Scheme

Acusera 24.7 Live Online

Guide to Running Quality Control

Medical Lab Professionals Week 2016

QC Serology Video

Acusera 247 Video

Acusera 24•7 Interlaboratory Data Management

Customer Testimonial | Adrian Cudmore NHS

Customer Testimonial | DR Caje Moniz NHS

Customer Testimonial | Dr Rosa Sierra Amor

Customer Testimonial | Dr Bianca Thakkar

Customer Testimonial | Dr. Anil Shah

Customer Testimonial | Dr Pragati Desai

Customer Testimonial | Dr Pramod Ingale

Customer Testimonial | Dr Rajeev Mehta

Customer Testimonial | Dr Simple Bhuptani

Customer Testimonial | Dr SM Patel

Customer Testimonial | Dr Trupti Patel

Customer Testimonial | Dr A Vahed Mulla


Randox QC Resource Hub

  • Brochures
  • Support Tools
  • Educational Items
  • Posters
  • Industry Articles
  • Webinars
  • Videos
  • Blog
  • Testimonials

Acusera Third Party Controls

Acusera 24•7

Infectious Disease Controls (Serology)

Importance of Third Party Controls

Acusera Point of Care Controls

Acusera Linearity Sets

IQC - Liquid 30 Day Controls

RIQAS External Quality Assessment

RIQAS Point of Care (RIQAS POC)

Qnostics - Molecular Infectious Disease Controls

QCMD - EQA for Molecular Infectious Disease Testing

International Brochures

Download our brochures in other languages

How to Establish QC Reference Ranges

The Cost of Poor Quality in the Clinical Laboratory

The Role of Six Sigma in a Modern QC Strategy

How Often Is Right For QC - Download

How Often Is Right For QC

How To Measure Uncertainty

ISO 15189:2012 Accreditation Guide

QC Multi-Rules

The Role of EQA in QC

Troubleshooting QC Errors

What Format Is Best For Your Laboratory - Download

What Format Is Best For Your Laboratory

Which QC is The Right QC - Downloads

Which QC is The Right QC

Basic QC Statistics

Commutability

Designing An Appropriate QC Design Procedure

ISO 15189 Requirements for Measurement Uncertainty

Quality Control for POCT - Download

Quality Control for POCT

Importance of Third Party Controls in Molecular Infectious Disease Testing

QC Statistics Infographic - Download

QC Statistics Infographic

The Difference Between IQC & EQA - Download

The Difference Between IQC & EQA

Linearity Verification Clinical Chemistry - Download

Linearity Verification Clinical Chemistry

Linearity Verification Cardiac - Download

Linearity Verification Cardiac

Using QC Multi-rules - Download

Using QC Multi-Rules

Preparing QC - Step-by-Step Guide - Download

Preparing QC - Step-by-Step Guide

Monitoring EQA Performance - Download

Monitoring EQA Performance

Guide to Running QC - Download

Guide to Running QC

RIQAS Frequency - Lipase

RIQAS Past Panels Flyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Using Sigma metrics and Measurement Uncertainty in QC – MLO

Using Sigma metrics and Measurement Uncertainty in QC – MLO

RIQAS Report Interpretation

Importance of Third Party Controls in Molecular Diagnostics

Fully syndromic approach to molecular testing

SARS-CoV-2 Proficiency Testing

RIQAS Reporting

The Role of EQA in QC Management

Importance of EQA

Utilisation of QC Software for Identification of Performance Issues

Why is the third party QC important for COVID-19 detection in Molecular testing

Importance of Third Party Controls in Molecular Diagnostics

Performance & Statistics - How EQA Can Help You Excel

Acusera 24•7 Webinar: Utilisation of QC software and metrics to help identify performance issues

The Need for Robust Molecular Quality Assurance in the Wake of the Pandemic

Acusera Third Party Controls

True Third Party Controls

Randox Acusera Quality Controls

Consolidation

RIQAS – External Quality Assessment Scheme

Acusera 24.7 Live Online

Guide to Running Quality Control

Medical Lab Professionals Week 2016

QC Serology Video

Acusera 247 Video

Acusera 24•7 Interlaboratory Data Management

Customer Testimonial | Adrian Cudmore NHS

Customer Testimonial | DR Caje Moniz NHS

Customer Testimonial | Dr Rosa Sierra Amor

Customer Testimonial | Dr Bianca Thakkar

Customer Testimonial | Dr. Anil Shah

Customer Testimonial | Dr Pragati Desai

Customer Testimonial | Dr Pramod Ingale

Customer Testimonial | Dr Rajeev Mehta

Customer Testimonial | Dr Simple Bhuptani

Customer Testimonial | Dr SM Patel

Customer Testimonial | Dr Trupti Patel

Customer Testimonial | Dr A Vahed Mulla


Anti-Müllerian Hormone (AMH) Quality Control

Therapeutic Drug Quality Control

The Randox Acusera AMH control is designed for use as a third-party control for the quantitative determination of Anti-Müllerian Hormone (AMH). An AMH test is often used to check a woman’s ability to produce eggs that can be fertilized for pregnancy. Thus, helping women to make informed decisions about their health.

Available in a liquid frozen format, this control should be treated in the same manner as a patient sample.

 

Features & Benefits

  • 30-day stability at +2°C to +8°C
  • Liquid Frozen format for convenience and reduced handling errors
  • True third-party control providing an unbiased assessment of performance
  • Manufactured using human serum, ensuring commutable sample matrix
  • Assayed target values provided eliminating the need to assign values in-house
  • Control available at recommended cut-off values for AMH

 

DescriptionPack SizeCat. NumberTypical Values
Beckman DXL / Roche ng/ml
 
AMH Control 13 x 2mlAMH105090.5
AMH Control 23 x 2mlAMH105141.0
AMH Control 33 x 2mlAMH105156.0
AMH Control 43 x 2mlAMH1051616.0

Analyte

  • Anti-Müllerian Hormone (AMH)

Serum Indices Quality Control

Therapeutic Drug Quality Control

The Randox Acusera Serum Indices control is designed to be used to monitor an IVD instrument’s response in the detection of haemolyzed, icteric and lipemic (HIL) samples. This control can be utilised in laboratory interference testing to assist in improving error detection of pre-analytical errors affecting clinical chemistry testing.

This control provides a full range of clinically relevant testing levels, including a negative (-) and three positives (+, ++ & +++)

Features & Benefits

  • Lyophilised for enhanced stability
  • Manufactured using human serum, ensuring commutable sample matrix
  • 2-year shelf life from date of manufacture
  • True third party control providing unbiased assessment of performance
  • Reconstituted stability of 14 days at 2°C – 8°C
  • 4 separate levels available including -, +, ++ & +++
DescriptionPack Size AnalytesCat. Number
Serum Indices Control4 x 5 ml3SI10448

Analytes

  • Haemolysis (H)
  • Icterus (I)
  • Lipemia (L)

Cardiac Quality Control

Therapeutic Drug Quality Control

Intended for use with Roche Abbott and Siemens systems, this control is manufactured using only the highest quality material and offers a 7-day thawed stability at +2ºC to +8ºC.

This control provides a full range of clinically relevant testing levels, including High Sensitivity Troponin I.

Features & Benefits

  • Liquid for ease-of-use stability
  • Aqueous Material
  • 4 Clinically relevant levels (including Ultra-Low)
  • Stable to expiry date at -18-24ºC storage
  • Thawed stability of 7 days at 2°C – 8°C
DescriptionOptimised forSize AnalytesCat No 
Cardiac Control - Ultra LowRoche (NT proBNP) & Abbott (Troponin I)3 x 3 ml2CQ10453
Cardiac Control Level 1Roche (NT proBNP) & Abbott (Troponin I)3 x 3 ml2CQ10454
Cardiac Control Level 2Roche (NT proBNP) & Abbott (Troponin I)3 x 3 ml2CQ10455
Cardiac Control Level 3Roche (NT proBNP) & Abbott (Troponin I)3 x 3 ml2CQ10456
Cardiac Control Ultra LowSiemens3 x 3 ml2CQ10428
Cardiac Control Level 1Siemens3 x 3 ml2CQ10429
Cardiac Control Level 2Siemens3 x 3 ml2CQ10430
Cardiac Control Level 3Siemens3 x 3 ml2CQ10431

Analytes

  • Troponin I
  • NT-proBNP

Neonatal Bilirubin External Quality Assessment

The RIQAS Neonatal Bilirubin EQA programme has been designed to assess the performance of total and direct bilirubin assays with levels tailored to neonatal bilirubin testing.

  • Lyophilised for enhanced stability
  • Monthly reporting
  • Human based serum
  • Submit results and view reports online via RIQAS.net
  • Rapid turnaround of reports allows for any necessary corrective actions to be taken with minimal disruption to laboratory output

Not accredited to ISO/IEC 17043

Cat NoKit SizeFrequencyCycle StartParameters 
RQ91912 x (6x3ml)MonthlyJuly2

Parameter

  • Direct Bilirubin
  • Total Bilirubin

Please note, product availability may vary country to country.


Liquid Bilirubin Control

Therapeutic Drug Quality Control

Providing a true third party solution for the measurement of Bilirubin, the new Acusera Liquid Bilirubin Control is designed to deliver an unbiased, independent assessment of analytical performance helping to ensure accurate and reliable patient testing.

Two levels are available, covering the required clinically relevant decision levels for neonatal testing of Driect and Total Bilirubin. With a 14 day open vial stability and 2 year shelf life the Acusera Liquid Bilirubin Control will reduce waste, whilst remaining easy and convenient to use.

Features & Benefits

  • Liquid frozen
  • 100% human serum
  • 2 year shelf life from date of manufacture
  • Clinically relevant decision levels, recommended by ISO15189
  • Open vial stability of 14 days at 2°C – 8°C
  • Assayed Control
  • CE Marked
DescriptionSizeAnalytesCat No. 
Liquid Bilirubin Control Level 13x3mLDirect Bilirubin
Total Bilirubin
BR10442
Liquid Bilirubin Control Level 23x3mLDirect Bilirubin
Total Bilirubin
BR10443

 

Analytes

  • Direct Bilirubin
  • Total Bilirubin

Related Products